Rosenstock J et al. conducted the PIONEER 3 trial to compare the effectiveness of oral Semaglutide against Sitagliptin in adult Type 2 diabetes patients who were not adequately controlled on Metformin alone or with sulfonylurea. This study robustly evaluated the impacts on HbA1c reduction and the changes in body weight from baseline (1). Study Summary About the Author Ms. Silpa Rani Gajavalli is a postgraduate in pharmaceutical science (M Pharmacy). She has a wealth of acad